{
    "organizations": [],
    "uuid": "f1dd823d501c92b4126a70a660f06fbc705160e8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mizuho-medy-obtains-marketing-and/brief-mizuho-medy-obtains-marketing-and-manufacture-approval-of-mycoplasma-nucleic-acid-kit-for-genetic-poct-examination-idUSL4N1QC0V5",
    "ord_in_thread": 0,
    "title": "BRIEF-Mizuho Medy obtains marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Mizuho Medy Co Ltd\n* Says it obtained the marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination in Japan on Feb. 19\nSource text in Japanese: goo.gl/LVabQk\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-22T10:46:00.000+02:00",
    "crawled": "2018-02-22T18:05:47.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "mizuho",
        "medy",
        "co",
        "ltd",
        "say",
        "obtained",
        "marketing",
        "manufacture",
        "approval",
        "mycoplasma",
        "nucleic",
        "acid",
        "kit",
        "genetic",
        "poct",
        "examination",
        "japan",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}